DOSSIER · 13F Holders · Q1 2026Healthcare · Biological Products, (No Diagnostic Substances)
NVAX
NOVAVAX INC
277 institutions still hold NOVAVAX INC as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 670002401·Biological Products, (No Diagnostic Substances)·277 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
277 institutions reported NVAX in Q1 2026. SHAH CAPITAL MANAGEMENT leads at 14.5% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 14
257 more holders available. Log in →